TOWNSEND RICHARD NOLAN (Chief Executive Officer) received a stock award from LEXEO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/28/2026ACC: 0001995218-26-000017
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+147.81K
Net shares
Net buyer
$6.1K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
147.81K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.31K
Price / share
$2.64
Trade value
$6.10K
% of position
0.6%
9/14/2026
374.47K→376.78K
Total
Net shares
+2.31K
Net value
$6.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/14/2026 | A · Award | +2.31K | $2.64 | $6.10K | 0.6% | 374.47K | 376.78K |
| Total | +2.31K | $6.10K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
145.50K shares
Shares
+145.50K
Strike price
3.39
Held after
145.50K
Exercisable
—
9/24/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock145.50K shares | 9/24/2026 | A · Award | +145.50K | 3.39 | — | 145.50K |